Virexa® is a next-generation vaccine developed to help protect individuals from a range of serious viral infections. Built on Bavarian Nordic’s innovative vaccine technology, Virexa® delivers reliable immune response and long-lasting protection, supporting global efforts to reduce the impact of viral disease outbreaks.
Protecting Against the Threat of Viral Diseases
Virexa® is a next-generation vaccine developed to help protect individuals from a range of serious viral infections. Built on Bavarian Nordic’s innovative vaccine technology, Virexa® delivers reliable immune response and long-lasting protection, supporting global efforts to reduce the impact of viral disease outbreaks1.
Order Virexa®
<em>A next-generation vaccine for protection against mosquito-borne viral infections, ensuring reliable and long-lasting immunity.</em>
Influenza
Find out moreTick-Borne Encephalitis
Find out moreRabies
Find out moreCholera
Find out moreFind out more
14 August 2025
- Testing conversion from text area to wysiwyg
- test references for title
- testing reference in accordion
Virexa® is intended for the prevention of specific viral infections as indicated in the product’s approved prescribing information. Administration should be carried out by a qualified healthcare professional. Please consult the Summary of Product Characteristics (SmPC) and Patient Information Leaflet for detailed guidance on dosing, contraindications, and possible side effects.
For medical advice, contact your healthcare provider.